COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,314 Articles (22,772 medRxiv, 8,542 bioRxiv)

Most recent first Previous |  Page 991: Articles 9901-9910  | Next

Seroprevalence of anti-SARS coronavirus 2 antibodies in Thai adults during the first three epidemic waves
Lerdsamran, H., Mungaomklang, A., Iamsirithaworn, S., Prasertsopon, J., Wiriyarat, W., Saritsiri, S., Anusorntanawat, R., Siriyakorn, N., Intalapaporn, P., Sirikhetkon, S., Sangsiriwut, K., Dangsakul, W., Sawadpongpan, S., Thinpan, N., Okada, P., Techasuwanna, R., Mongkalangoon, N., Prasert, K., Puthavathana, P.
10.1101/2022.01.18.22269501 — Posted: 2022-01-21
SARS-CoV-2 surveillance (09/2020 - 03/2021) in elementary schools and daycare facilities in Bavaria
Kern, A., Kuhlmann, P. H., Matl, S., Ege, M., Maison, N., Eckert, J., von Both, U., Behrends, U., Anger, M., Frühwald, M. C., Gerstlauer, M., Woelfle, J., Neubert, A., Melter, M., Liese, J., Goettler, D., Sing, A., Liebl, B., Hübner, J., Klein, C., COVID Kids Bavaria Consortium
10.1101/2022.01.18.22269445 — Posted: 2022-01-21
Safety Profile of Sinopharm COVID-19 Vaccine and Breakthrough Infections in Pakistan
Rizwan, W., Qureshi, A. U., Rana, M. N., Duggal, M. N., Sohaib, M., Sadiq, M.
10.1101/2022.01.18.22268965 — Posted: 2022-01-21
Effectiveness of BNT162b2 and mRNA-1273 COVID-19 boosters against SARS-CoV-2 Omicron (B.1.1.529) infection in Qatar
Abu-Raddad, L. J., Chemaitelly, H., Ayoub, H. H., AlMukdad, S., Tang, P. J., Hasan, M. R., Coyle, P., YASSINE, H. M., Al-Khatib, H. A., Smatti, M. K., Al-Kanaani, Z., Al-Kuwari, E., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Abdul-Rahim, H. F., Nasrallah, G., Al-Kuwari, M. G., Butt, A. A., Al-Romaihi, H. E., Al-Thani, M. H., Al-Khal, A., Bertollini, R.
10.1101/2022.01.18.22269452 — Posted: 2022-01-21
Testing behaviour may bias observational studies of vaccine effectiveness
Glasziou, P., McCaffery, K. J., Cvejic, E., Batcup, C., Ayre, J., Pickles, K., Bonner, C.
10.1101/2022.01.17.22269450 — Posted: 2022-01-21
An expanded high throughput RT-PCR assay to rapidly identify all known SARS-CoV-2 variants of concern using melting temperature coding.
Banada, P. P., Green, R., Banik, S., Streck, D., Montalvan, I., Reiss, R., Jones, R., Marras, S., Chakravorty, S., Alland, D.
10.1101/2022.01.18.22269424 — Posted: 2022-01-21
Investigating sensitivity of nasal or throat (ISNOT): A combination of both swabs increases sensitivity of SARS-CoV-2 rapid antigen tests
Goodall, B. L., LeBlanc, J. J., Hatchette, T. F., Barrett, L., Patriquin, G.
10.1101/2022.01.18.22269426 — Posted: 2022-01-21
mRNA-COVID19 vaccination can be considered safe and tolerable for frail patients
Teresa Lupo Stanghellini, M., Di Cosimo, S., Costantini, M., Monti, S., Mantegazza, R., Mantovani, A., Salvarani, C., Luigi Zinzani, P., Inglese, M., Ciceri, F., Apolone, G., Ciliberto, G., Baldanti, F., Morrone, A., Sinno, V., Locatelli, F., Notari, S., Turola, E., Giannarelli, D., Silvestris, N.
10.1101/2022.01.18.22269351 — Posted: 2022-01-21
Combination of Spironolactone and Sitagliptin Improves Clinical Outcomes of Outpatients with COVID-19: An Observational Study
Davarpanah, M. A., Adatorwovor, R., Mansoori, Y., Ramsheh, F. S. R., Parsa, A., Hajiani, M., Faramarzi, H., Kavuluru, R., Asadipooya, K.
10.1101/2022.01.21.22269322 — Posted: 2022-01-21
ReadItAndKeep: rapid decontamination of SARS-CoV-2 sequencing reads
Hunt, M., Swann, J., Constantinides, B., Fowler, P. W., Iqbal, Z.
10.1101/2022.01.21.477194 — Posted: 2022-01-21

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).